Colorado biotech's knee osteoarthritis drug gets good results, stock soars
Shares in Ampio Pharmaceuticals Inc. were soaring in early Thursday trading after the Douglas County biotech reported good results from a trial of its knee osteoarthritis drug Ampion.
Shares in Ampio (NYSE: AMPE) were up more than 40 percent early Thursday, rising 80 cents to $2.55.
Ampio said patients in the trial experienced, on average a 53 percent decrease in pain, a 50 percent improvement in function, and a 45 percent improvement in quality of life.
"We are very pleased with the positive…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Ben Miller Source Type: news